Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2000 Nov;84(11):1244–1249. doi: 10.1136/bjo.84.11.1244

Mooren's ulcer in China: a study of clinical characteristics and treatment

J Chen 1, H Xie 1, Z Wang 1, B Yang 1, Z Liu 1, L Chen 1, X Gong 1, Y Lin 1
PMCID: PMC1723298  PMID: 11049948

Abstract

AIMS—To investigate the clinical characteristics and compare the effects of several methods of treatment of Mooren's corneal ulcer.
METHODS—550 consecutive cases of Mooren's corneal ulcer were analysed in patients, including age, sex, laterality of eye, ulcer location, perforative rate, cure rate of surgeries, recurrent rate, the effects of conjunctiva excision, lamellar keratoplasty (LKP), and LKP plus 1% cyclosporin A eye drops.
RESULTS—The average age of onset was 48.4 years of age. The ratio of males to females was 1:0.74. 165 (30%) cases had the disease bilaterally, of which 52 (31.5%) occurred in the young age group and 113 (68.5%) in the old age group. Ulcers of 501 eyes (70.1%) were located at the limbus of the palpebral fissure. The perforation rate was 13.3%, with perforation of 41 eyes (43.2%) occurring in the young age group and 54 (56.8%) in the old age group. Postoperative recurrence rate was 25.6%. The cure rate of the first procedure of LKP plus 1% cyclosporin A eye drops was 73.7%. The final cure rate was 95.6%, and the postoperative preservation rate of the eye globe was 99.7%.
CONCLUSION—This primary study provided the clinical characteristics of patients with Mooren's corneal ulcer in China. LKP plus 1% cyclosporin A eye drops was an effective treatment.



Full Text

The Full Text of this article is available as a PDF (223.8 KB).

Figure 1  .

Figure 1  

Open in a new tab

Mooren's ulcer (slit lamp microscopic photograph).    

Figure 2  .

Figure 2  

Open in a new tab

Mooren's ulcer with a limbal perforation and iris herniation (slit lamp microscopic photograph).    

Figure 3  .

Figure 3  

Open in a new tab

Lymphocyte infiltration and new blood vessels of the cornea near Mooren's ulcer (haematoxylin and eosin, original magnification ×20).

Figure 4  .

Figure 4  

Open in a new tab

Lymphocyte infiltration, blood vessel dilatation, and oedema of the adjacent conjunctiva of Mooren's ulcer (haematoxylin and eosin, original magnification ×20).

Figure 5  .

Figure 5  

Open in a new tab

Crescent shaped lamellar keratoplasty (slit lamp microscopic photograph).

Figure 6  .

Figure 6  

Open in a new tab

Doughnut shaped lamellar keratoplasty (slit lamp microscopic photograph).

Figure 7  .

Figure 7  

Open in a new tab

Full lamellar keratoplasty (slit lamp microscopic photograph).

Figure 8  .

Figure 8  

Open in a new tab

Double lamellar keratoplasty (slit lamp microscopic photograph, note inner graft with interrupted sutures).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown S. I., Mondino B. J., Rabin B. S. Autoimmune phenomenon in Mooren's ulcer. Am J Ophthalmol. 1976 Dec;82(6):835–840. doi: 10.1016/0002-9394(76)90058-1. [DOI] [PubMed] [Google Scholar]
  2. Gottsch J. D., Liu S. H., Minkovitz J. B., Goodman D. F., Srinivasan M., Stark W. J. Autoimmunity to a cornea-associated stromal antigen in patients with Mooren's ulcer. Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1541–1547. [PubMed] [Google Scholar]
  3. Kietzman B. Mooren's ulcer in Nigeria. Am J Ophthalmol. 1968 May;65(5):679–685. doi: 10.1016/0002-9394(68)94381-x. [DOI] [PubMed] [Google Scholar]
  4. Kinoshita S., Ohashi Y., Ohji M., Manabe R. Long-term results of keratoepithelioplasty in Mooren's ulcer. Ophthalmology. 1991 Apr;98(4):438–445. doi: 10.1016/s0161-6420(91)32272-3. [DOI] [PubMed] [Google Scholar]
  5. Lewallen S., Courtright P. Problems with current concepts of the epidemiology of Mooren's corneal ulcer. Ann Ophthalmol. 1990 Feb;22(2):52–55. [PubMed] [Google Scholar]
  6. Lopez J. S., Price F. W., Jr, Whitcup S. M., Li Q., de Smet M., Chan C. C. Immunohistochemistry of Terrien's and Mooren's corneal degeneration. Arch Ophthalmol. 1991 Jul;109(7):988–992. doi: 10.1001/archopht.1991.01080070100045. [DOI] [PubMed] [Google Scholar]
  7. Mondino B. J., Hofbauer J. D., Foos R. Y. Mooren's ulcer after penetrating keratoplasty. Am J Ophthalmol. 1987 Jan 15;103(1):53–56. doi: 10.1016/s0002-9394(14)74169-8. [DOI] [PubMed] [Google Scholar]
  8. Watson P. G. Management of Mooren's ulceration. Eye (Lond) 1997;11(Pt 3):349–356. doi: 10.1038/eye.1997.74. [DOI] [PubMed] [Google Scholar]
  9. Wood T. O., Kaufman H. E. Mooren's ulcer. Am J Ophthalmol. 1971 Jan;71(1 Pt 2):417–422. doi: 10.1016/0002-9394(71)90420-x. [DOI] [PubMed] [Google Scholar]
  10. Zegans M. E., Srinivasan M., McHugh T., Whitcher J. P., Margolis T. P., Lietman T., Jennette J. C., Cunningham E. T., Jr Mooren ulcer in South India: serology and clinical risk factors. Am J Ophthalmol. 1999 Aug;128(2):205–210. doi: 10.1016/s0002-9394(99)00162-2. [DOI] [PubMed] [Google Scholar]
  11. Zieske J. D., Bukusoglu G., Yankauckas M. A. Characterization of a potential marker of corneal epithelial stem cells. Invest Ophthalmol Vis Sci. 1992 Jan;33(1):143–152. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES